Powered by

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against FibroGen Inc.

Apr 07, 2021 - Business Wire

The law firm of Kirby McInerney LLP is investigating potential claims against FibroGen Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN ). The investigation focuses on the Company and its officers' possible violations of federal securities laws.

On April 6, 2021, after the market closed, FibroGen issued a statement "provid[ing] clarification of certain prior disclosures of U.S. primary cardiovascular safety analyses from the roxadustat Phase 3 program for the treatment of anemia of chronic...